Glucose monitoring specialist Dexcom announced it is expanding its diabetes management capabilities by offering direct connectivity to the Apple Watch of its G7 continuous glucose monitoring system through a dedicated Bluetooth connection.The feature allows…
Continue Reading
What You Should Know:
– Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous…
Continue Reading
What You Should Know:
– Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence…
Continue Reading
What You Should Know:
– Senseonics Holdings, Inc., a provider of long-term implantable continuous glucose monitoring (CGM) systems, today announced a strategic partnership with Rimidi. Rimidi offers a comprehensive clinical management platform designed to improve…
Continue Reading
Internet-based tracking and coaching are being employed wherever health becomes a matter of lifestyle. Technologies can reach into every detail of a patient’s life: how to eat when they visit a buffet, where’s a…
Continue Reading
Payers are always wary about funding new treatments for illnesses and conditions: When millions of dollars are at stake, payers want demonstrated improvements in outcomes. So do doctors and patients, before they go through…
Continue Reading
Roche has developed a continuous glucose monitor with predictive algorithms that gives patients with diabetes a way of managing their condition and reducing uncertainty, with a potentially powerful impact on their quality of life. Roche…
Continue Reading
Type 1 diabetes (T1D) is a chronic condition characterized by glucose fluctuations. Laboratory studies suggest that cognition is reduced when glucose is very low (hypoglycemia) and very high (hyperglycemia). Until recently, technological limitations prevented…
Continue Reading
An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA).Available without the need for a prescription, the wearable biosensor boasts a battery…
Continue Reading
What You Should Know:
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom – the first glucose biosensor that doesn’t…
Continue Reading
